Opinion: Brain Scans in the Courtroom

Advances in neuroimaging have improved our understanding of the brain, but the resulting data do little to help judges and juries determine criminal culpability.

Written byAndreas Kuersten
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WIKIMEDIA; UPPSALA UNIVERSITY HOSPITAL, MIKAEL HÄGGSTRÖMA group of men exit a city hotel and begin making their way to a waiting car. As they approach the vehicle, another man opens fire on the group from 10 feet away, intending to kill one of them. Four men are wounded before the attacker is subdued by bystanders.

Imagine you’re a juror in the shooter’s trial for attempted murder.

At trial, the shooter’s legal team pursues the insanity defense. The defense argues that, at the time of the offense, the accused—due to mental disease or defect—lacked substantial capacity to appreciate the wrongfulness of his actions or to conform to the requirements of the law. In support of this contention, the defense presents you and your fellow jurors with an image of the accused’s brain from a computerized axial tomography (CAT) scan. Accompanying this picture is the testimony of a defense expert, a neuroradiologist, saying that the shooter’s brain has relatively enlarged sulci and ventricles, signifying shrinkage and decay. A second defense expert, a psychiatrist, testifies that these characteristics are associated with schizophrenia.

To ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies